These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 23221719)
1. The PPARγ agonist protects cardiomyocytes from oxidative stress and apoptosis via thioredoxin overexpression. Kim YJ; Park KJ; Song JK; Shim TJ; Islam KN; Bae JW; Kim SM; Lee SY; Hwang KK; Kim DW; Cho MC; Ryu KH Biosci Biotechnol Biochem; 2012; 76(12):2181-7. PubMed ID: 23221719 [TBL] [Abstract][Full Text] [Related]
2. PPAR gamma protects cardiomyocytes against oxidative stress and apoptosis via Bcl-2 upregulation. Ren Y; Sun C; Sun Y; Tan H; Wu Y; Cui B; Wu Z Vascul Pharmacol; 2009; 51(2-3):169-74. PubMed ID: 19540934 [TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells. Meshkani R; Sadeghi A; Taheripak G; Zarghooni M; Gerayesh-Nejad S; Bakhtiyari S Cell Biochem Funct; 2014 Dec; 32(8):683-91. PubMed ID: 25431031 [TBL] [Abstract][Full Text] [Related]
4. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide. Sommer M; Wolf G Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750 [TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone via PPARγ-dependent suppression of oxidative stress attenuates endothelial dysfunction in rats fed homocysteine thiolactone. Yang XH; Li P; Yin YL; Tu JH; Dai W; Liu LY; Wang SX J Cell Mol Med; 2015 Apr; 19(4):826-35. PubMed ID: 25656735 [TBL] [Abstract][Full Text] [Related]
6. β-Blocker carvedilol protects cardiomyocytes against oxidative stress-induced apoptosis by up-regulating miR-133 expression. Xu C; Hu Y; Hou L; Ju J; Li X; Du N; Guan X; Liu Z; Zhang T; Qin W; Shen N; Bilal MU; Lu Y; Zhang Y; Shan H J Mol Cell Cardiol; 2014 Oct; 75():111-21. PubMed ID: 25066695 [TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins. Wu JS; Lin TN; Wu KK J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877 [TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis. Fuenzalida K; Quintanilla R; Ramos P; Piderit D; Fuentealba RA; Martinez G; Inestrosa NC; Bronfman M J Biol Chem; 2007 Dec; 282(51):37006-15. PubMed ID: 17965419 [TBL] [Abstract][Full Text] [Related]
9. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia. Berthiaume M; Laplante M; Tchernof A; Deshaies Y Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631 [TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptor γ-independent mitochondrial oxidative stress in mouse hearts. He H; Tao H; Xiong H; Duan SZ; McGowan FX; Mortensen RM; Balschi JA Toxicol Sci; 2014 Apr; 138(2):468-81. PubMed ID: 24449420 [TBL] [Abstract][Full Text] [Related]
11. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats. Cao Z; Ye P; Long C; Chen K; Li X; Wang H Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310 [TBL] [Abstract][Full Text] [Related]
12. [PPAR gamma agonist rosiglitazone alleviates hypoxia/reoxygenation-induced oxidative stress and apoptosis in rat cardiac myocytes]. Yao YJ; Geng DF; Wang JF; Yang MH; Zhang YL; Nie RQ; Zhou SX Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):689-93. PubMed ID: 19403396 [TBL] [Abstract][Full Text] [Related]
14. Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia. Chen Y; Chen H; Birnbaum Y; Nanhwan MK; Bajaj M; Ye Y; Qian J Diab Vasc Dis Res; 2017 Mar; 14(2):152-162. PubMed ID: 28111985 [TBL] [Abstract][Full Text] [Related]
15. Ameliorative effect of rosiglitazone, a peroxisome proliferator gamma agonist on adriamycin-induced cardio toxicity via suppressing oxidative stress and apoptosis. Zhang L; Wu P; Zhang L; SreeHarsha N; Mishra A; Su X IUBMB Life; 2020 Apr; 72(4):607-615. PubMed ID: 31660680 [TBL] [Abstract][Full Text] [Related]
16. Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes. Pang W; Li N; Ai D; Niu XL; Guan YF; Zhu Y Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):358-64. PubMed ID: 21291492 [TBL] [Abstract][Full Text] [Related]
17. Urotensin II Protects Cardiomyocytes from Apoptosis Induced by Oxidative Stress through the CSE/H2S Pathway. Gong H; Chen Z; Zhang X; Li Y; Zhang J; Chen Y; Ding Y; Zhang G; Yang C; Zhu Y; Zou Y Int J Mol Sci; 2015 Jun; 16(6):12482-98. PubMed ID: 26047336 [TBL] [Abstract][Full Text] [Related]
18. Tissue transglutaminase 2 promotes apoptosis of rat neonatal cardiomyocytes under oxidative stress. Song H; Kim BK; Chang W; Lim S; Song BW; Cha MJ; Jang Y; Hwang KC J Recept Signal Transduct Res; 2011 Feb; 31(1):66-74. PubMed ID: 21067463 [TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation. Villegas I; Martín AR; Toma W; de la Lastra CA Eur J Pharmacol; 2004 Nov; 505(1-3):195-203. PubMed ID: 15556153 [TBL] [Abstract][Full Text] [Related]
20. Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepatocyte. Wang X; Wang Z; Liu JZ; Hu JX; Chen HL; Li WL; Hai CX Toxicol In Vitro; 2011 Jun; 25(4):839-47. PubMed ID: 21333731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]